The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Specific Binding of Nisin to the Peptidoglycan Precursor Lipid II Combines Pore Formation and Inhibition of Cell Wall Biosynthesis for Potent Antibiotic Activity
Open accessAbstract
Unlike numerous pore-forming amphiphilic peptide antibiotics, the lantibiotic nisin is active in nanomolar concentrations, which results from its ability to use the lipid-bound cell wall precursor lipid II as a docking molecule for subsequent pore formation. Here we use genetically engineered nisin variants to identify the structural requirements for the interaction of the peptide with lipid II. Mutations affecting the conformation of the N-terminal part of nisin comprising rings A through C, e.g. [S3T]nisin, led to reduced binding and increased the peptide concentration necessary for pore formation. The binding constant for the S3T mutant was 0.043 x 10(7) m(-1) compared with 2 x 10(7) m(-1) for the wild-type peptide, and the minimum concentration for pore formation increased from the 1 nm to the 50 nm range. In contrast, peptides mutated in the flexible hinge region, e.g. [DeltaN20/DeltaM21]nisin, were completely inactive in the pore formation assay, but were reduced to some extent in their in vivo activity. We found the remaining in vivo activity to result from the unaltered capacity of the mutated peptide to bind to lipid II and thus to inhibit its incorporation into the peptidoglycan network. Therefore, through interaction with the membrane-bound cell wall precursor lipid II, nisin inhibits peptidoglycan synthesis and forms highly specific pores. The combination of two killing mechanisms in one molecule potentiates antibiotic activity and results in nanomolar MIC values, a strategy that may well be worth considering for the construction of novel antibiotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rouser, G., Fleischer, S., & Yamamoto, A. (1970) · Lipids · doi:10.1007/bf02531316 · Cited by 3,274
Hope, M. J., Bally, M. B., Webb, G., & Cullis, P. R. (1985) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(85)90521-8 · Cited by 2,076
Peschel, A., Otto, M., Jack, R. W., Kalbacher, H., Jung, G., & Götz, F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8405 · Cited by 994
Use of the Cell Wall Precursor Lipid II by a Pore-Forming Peptide Antibiotic
Breukink, E., Wiedemann, I., Kraaij, C. V., Kuipers, O. P., Sahl, H.-G., & de Kruijff, B. (1999) · Science · doi:10.1126/science.286.5448.2361 · Cited by 814
Self-citationGross, E., & Morell, J. L. (1971) · Journal of the American Chemical Society · doi:10.1021/ja00747a073 · Cited by 605
Sahl, H.-G., & Bierbaum, G. (1998) · Annual Review of Microbiology · doi:10.1146/annurev.micro.52.1.41 · Cited by 476
Self-citationHurst, A. (1981) · Advances in Applied Microbiology · doi:10.1016/s0065-2164(08)70342-3 · Cited by 453
Brötz, H., Josten, M., Wiedemann, I., Schneider, U., Götz, F., Bierbaum, G., & Sahl, H. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.01065.x · Cited by 421
Self-citationThe Lantibiotic Mersacidin Inhibits Peptidoglycan Synthesis by Targeting Lipid II
Brötz, H., Bierbaum, G., Leopold, K., Reynolds, P. E., & Sahl, H.-G. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.1.154 · Cited by 381
Self-citationRuhr, E., & Sahl, H. G. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.27.5.841 · Cited by 375
Self-citationvan der Meer, J. R., Polman, J., Beerthuyzen, M. M., Siezen, R. J., Kuipers, O. P., & De Vos, W. M. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.9.2578-2588.1993 · Cited by 318
Self-citationRadiolabeling of proteins by reductive alkylation with [14C]formaldehyde and sodium cyanoborohydride
Dottavio-Martin, D., & Ravel, J. M. (1978) · Analytical Biochemistry · doi:10.1016/0003-2697(78)90706-6 · Cited by 311
Mechanistic studies of lantibiotic-induced permeabilization of phospholipid vesicles
Driessen, A. J. M., van den Hooven, H. W., Kuiper, W., Van de Camp, M., Sahl, H.-G., Konings, R. N. H., & Konings, W. N. (1995) · Biochemistry · doi:10.1021/bi00005a017 · Cited by 225
Self-citationProperties of nisin Z and distribution of its gene, nisZ, in Lactococcus lactis
de Vos, W. M., Mulders, J. W., Siezen, R. J., Hugenholtz, J., & Kuipers, O. P. (1993) · Applied and Environmental Microbiology · doi:10.1128/aem.59.1.213-218.1993 · Cited by 219
Self-citationPathogenesis of urinary tract infections: an update
Hooton, T. M. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.suppl_1.1 · Cited by 212
The Lantibiotic Mersacidin Inhibits Peptidoglycan Biosynthesis at the Level of Transglycosylation
Brötz, H., Bierbaum, G., Reynolds, P. E., & Sahl, H. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.t01-1-00193.x · Cited by 199
Self-citationEngineering dehydrated amino acid residues in the antimicrobial peptide nisin.
Kuipers, O. P., Rollema, H. S., Yap, W. M., Boot, H. J., Siezen, R. J., & de Vos, W. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35771-5 · Cited by 196
Self-citationSahl, H. G., Kordel, M., & Benz, R. (1987) · Archives of Microbiology · doi:10.1007/bf00425076 · Cited by 191
Self-citationBreukink, E., van Kraaij, C., Demel, R. A., Siezen, R. J., Kuipers, O. P., & de Kruijff, B. (1997) · Biochemistry · doi:10.1021/bi970008u · Cited by 175
Self-citationAntibacterial peptides designed as analogs or hybrids of cecropins and melittin
Wade, D. C., Andreu, D., MITCHELL, S. A., Silveira, A. M. V., Boman, A., Boman, H. G., & Merrifield, R. B. (1992) · International journal of peptide & protein research · doi:10.1111/j.1399-3011.1992.tb00321.x · Cited by 157
Modifications of membrane phospholipid composition in nisin-resistant Listeria monocytogenes Scott A
Verheul, A., Russell, N. J., Hof, R. V., ROMBOUTS, F. M., & Abee, T. (1997) · Applied and Environmental Microbiology · doi:10.1128/aem.63.9.3451-3457.1997 · Cited by 155
Kinetics of Pore Formation by an Antimicrobial Peptide, Magainin 2, in Phospholipid Bilayers
Matsuzaki, K., Murase, O., & Miyajima, K. (1995) · Biochemistry · doi:10.1021/bi00039a009 · Cited by 154
Brötz, H., & Sahl, H. G. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.1.1 · Cited by 147
Self-citationA Powerful Inhibitory Substance Produced by Group N Streptococci
Mattick, A. T. R., & HIRSCH, A. (1944) · Nature · doi:10.1038/154551a0 · Cited by 128
Protein engineering of lantibiotics
Kuipers, O. P., Bierbaum, G., Ottenwälder, B., Dodd, H. M., Horn, N., Metzger, J. W., Kupke, T. E., Gnau, V., Bongers, R. S., van den Bogaard, P., et al. (1996) · Antonie van Leeuwenhoek · doi:10.1007/bf00399421 · Cited by 124
Self-citationIsolation and characterisation of two degradation products derived from the peptide antibiotic nisin
Chan, W. C., Bycroft, B. W., Lian, L., & Roberts, G. C. K. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)80884-1 · Cited by 103
van den Hooven, H. W., Doeland, C. C. M., KAMP, M. V. D., Konings, R. N. H., Hilbers, C. W., & van de Ven, F. J. M. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.00382.x · Cited by 100
Mechanism of lantibiotic-induced pore-formation
Moll, G. N., Roberts, G. C. K., Konings, W. N., & Driessen, A. J. M. (1996) · Antonie van Leeuwenhoek · doi:10.1007/bf00399423 · Cited by 85
Kuipers, O. P., Rollema, H. S., de Vos, W. M., & Siezen, R. J. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80911-d · Cited by 84
Self-citationIsolation and characterization of genetically engineered gallidermin and epidermin analogs
Ottenwälder, B., Kupke, T. E., Brecht, S., Gnau, V., Metzger, J. W., Jung, G., & Götz, F. (1995) · Applied and Environmental Microbiology · doi:10.1128/aem.61.11.3894-3903.1995 · Cited by 73
van Kraaij, C., Breukink, E. J., Rollema, H. S., Siezen, R. J., DEMEL, R. A., KRUIJFF, B. D., & Kuipers, O. P. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00114.x · Cited by 60
Self-citationStructural similarities of the staphylococcin-like peptide Pep-5 to the peptide antibiotic nisin
Sahl, H., Grossgarten, M., Widger, W. R., Cramer, W. A., & Brandis, H. J. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.27.5.836 · Cited by 59
Self-citationEngineering a disulfide bond and free thiols in the lantibiotic nisin Z
van Kraaij, C., Breukink, E. J., Rollema, H. S., et al. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01075.x · Cited by 48
Self-citation
Cited by
A new antibiotic kills pathogens without detectable resistance
Ling, L. L., Schneider, T., Peoples, A. J., Spoering, A. L., Engels, I., Conlon, B. P., Mueller, A., Schäberle, T. F., Hughes, D. E., Epstein, S., et al. (2015) · Nature · doi:10.1038/nature14098 · Cited by 2,428
Bacteriocins: Developing innate immunity for food
Cotter, P. D., Hill, C., & Ross, R. P. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1273 · Cited by 2,380
The co-evolution of host cationic antimicrobial peptides and microbial resistance
Peschel, A., & Sahl, H.-G. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1441 · Cited by 1,062
Self-citationPreservation and Fermentation: Past, Present and Future
Paul Ross, R., Morgan, S., & Hill, C. (2002) · International Journal of Food Microbiology · doi:10.1016/s0168-1605(02)00174-5 · Cited by 942
Insights into the mode of action of chitosan as an antibacterial compound.
Raafat, D., von Bargen, K., Haas, A., & Sahl, H.-G. (2008) · Applied and Environmental Microbiology · doi:10.1128/aem.00453-08 · Cited by 888
Self-citation
Metadata
- Authors
- Wiedemann, I., Breukink, E., van Kraaij, C., Kuipers, O. P., Bierbaum, G., de Kruijff, B., & Sahl, H.-G.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2001-01
- Volume
- 276
- Issue
- 3
- Pages
- 1772-1779
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2148851922
- Cited by
- 790
- References
- 33
- FWCI
- 18.63
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.